Cargando…
Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status
INTRODUCTION: Relationships of parity with breast cancer risk are complex. Parity is associated with decreased risk of postmenopausal hormone receptor–positive breast tumors, but may increase risk for basal-like breast cancers and early-onset tumors. Characterizing parity-related gene expression pat...
Autores principales: | Rotunno, Melissa, Sun, Xuezheng, Figueroa, Jonine, Sherman, Mark E, Garcia-Closas, Montserrat, Meltzer, Paul, Williams, Tyisha, Schneider, Sallie Smith, Jerry, D Joseph, Yang, Xiaohong R, Troester, Melissa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227137/ https://www.ncbi.nlm.nih.gov/pubmed/25005139 http://dx.doi.org/10.1186/bcr3689 |
Ejemplares similares
-
TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study
por: Hurson, Amber N., et al.
Publicado: (2022) -
Challenges in studying the etiology of breast cancer subtypes
por: Troester, Melissa A, et al.
Publicado: (2009) -
Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases
por: Hurson, Amber N., et al.
Publicado: (2022) -
Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44(high)/cd24(low )population which is invasive and resistant to anoikis
por: Gauger, Kelly J, et al.
Publicado: (2009) -
Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype
por: Couture, Heather D., et al.
Publicado: (2018)